Expression and its clinical significance of SLC22a18 in non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 15, Issue 1, 2012, Pages 17-20

  Lei, Ming ^a   Cheng, Qingshu ^a   Zhao, Yachao ^a   Liu, Tao ^a   Wang, Xuejiao ^a   Deng, Yingchun ^a   Yang, Jing ^a   Zhang, Zhipei ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Immunohistochemistry; Lung neoplasms; SLC22A18

Indexed keywords

CARRIER PROTEIN; PROTEIN SLC22A18; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; GENE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NON SMALL CELL LUNG CANCER; PROTEIN EXPRESSION; SLC22A18 GENE;

EID: 84922685523     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2012.01.04     Document Type: Article

References (11)

1. Yang L, Li LD, Chen YD, et al. Mortality time trends and the incidence and mortality estimation and projection for lung cancer in China. Chin J Lung Cancer, 2005, 8(4): 274-278.
2. Chen WQ, Zhang SW, Zou XN, et al. An analysis of lung cancer mortality in. China, 2004-2005. Chin J Prev Med, 2010, 44(5): 378-382.
3. Merk J, Rolff J, Dorn C, et al. Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy? Eur J Cardiothorac Surg, 2011, 40(1): 29-33.
4. Yamada HY, Gorbsky GJ. Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel ubiquitin ligase RING105. Oncogene, 2006, 25(9): 1330-1339.
5. Bajaj V, Singhmar P, Kumar A. Promoter characterization and regulation of expression of an imprinted gene SLC22A18AS. Gene, 2008, 424(1-2): 40-47.
6. Reece M, Prawitt D, Landers J, et al. Functional characterization of ORCTL2-an organic cation transporter expressed in the renal proximal tubules. FEBS Lett, 1998, 433(3): 245-250.
7. Chu SH, Feng DF, Ma YB, et al. Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma. J Transl Med, 2011, 9: 156
8. Tirona RG, Kim RB. Pharmacogenomics of organic anion-transporting polypeptides (OATP). Adv Drug Deliv Rev, 2002, 54(10): 1343-1352
9. Yang BP, Ren RM. Advance of breast cancer resistance protein. Chin J Mod Med, 2006, 16(11): 1678-1681
10. Wang J, Xu HM, Shen YW, et al. Effects of SLC22A18 over-expression on sensitivity to chemotherapeutic agents in human breast cancer cell MCF-7. Chin J Exp Surg, 2009, 26(9): 1343-1352
11. Lee MP, Reeves C, Schmitt A, et al. Somatic mutation of TSSC5, a novel imprinted gene from human chromosome 11p15.5. Cancer Res, 1998, 58(18): 4155-4159.